Diabetes

WASHINGTON — U.S. News Media Group on Tuesday ranked the best dieting plans by health goal — identifying the best plans for weight loss, heart health and diabetes.

Building on the company’s experience evaluating hospitals, U.S. News developed five diet rankings to address a broad range of consumers' dieting goals and needs. Diets were ranked based on ratings from an independent panel of 22 experts.

RALEIGH, N.C. — Kerr Drug is hosting the North Carolina launch of the National Consumer League’s “Script Your Future” medication adherence campaign, the regional retail pharmacy chain said.

COPENHAGEN, Denmark — A new survey sponsored by drug maker Novo Nordisk, which polled Type 1 and Type 2 diabetes patients in the United States, United Kingdom, Germany and France, found that about 1-in-5 respondents regularly are unable to attend a full day of work due to disruption caused by episodes of dangerously low blood sugar, also known as hypoglycemic events.

SAN DIEGO — An investigational drug improved diabetes and lipid control in patients with partial lipodystrophy, according to a new study.

Amylin Pharmaceuticals announced Saturday results of a study of metreleptin, an analog of the human hormone leptin. Results of the study were presented at the 93rd annual meeting and expo of the Endocrine Society in Boston.

STOCKHOLM — Swedish drug maker Diamyd Medical has regained control of its investigational drug for Type 1 diabetes following Johnson & Johnson’s termination of a development deal between the two companies.

WOONSOCKET, R.I. — CVS Caremark's MinuteClinic locations are offering a free diabetes monitoring package this summer, the company announced on Friday.

The monitoring package administered by a MinuteClinic practitioner includes hemoglobin A1C and blood glucose tests, a blood pressure check, body mass index, cholesterol test, comprehensive foot exam and microalbumin test (kidney function check). The practitioner also will conduct a review of lifestyle factors and give immediate results and recommendations.

WINSTON-SALEM, N.C. — The gold standard long-term glucose monitoring test for patients with diabetes proved to be of limited value in dialysis patients, according to a new study at Wake Forest Baptist Medical Center released Wednesday.

BEDFORD, Mass. — A company that develops insulin-pump technology without tubing, such as the OmniPod insulin management system, has acquired a durable medical equipment distributor that specializes in direct-to-consumer sales of diabetes supplies.